The Fourth Hospital of Hebei Medical University

Shijiazhuang 50011

5 studies enrolling now · 8 studies all time

What they study most

Carcinoma, Squamous Cell, End Stage Kidney Disease, Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer, Hepatocellular Carcinoma (HCC), Locally Advanced Solid Tumors, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Solid Tumors, Monoclonal Antibody, Non-small Cell Lung Cancer, Primary Membranous Nephropathy

Studies at this site

• Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) — Recruiting now
• JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma — Recruiting now
• A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer — Recruiting now
• A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28) — Running, not enrolling
• A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors — Completed
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer — Running, not enrolling